Related Experiment Videos
Summary
Drug-induced Lupus Erythematosus Disseminatus (LED) can be triggered by various medications. This report details a case where Ethambutol exacerbated LED, adding it to the list of known causative agents.
Area of Science:
- Immunology
- Pharmacology
- Rheumatology
Context:
- Lupus Erythematosus Disseminatus (LED), also known as Visceral Lupus.
- Drug-induced lupus, or "Pseudo-LE-Syndrom," presents diverse immunologic and etiologic factors.
- Understanding drug-induced exacerbations is crucial for patient management.
Purpose:
- To report a case of Lupus Erythematosus Disseminatus (LED) exacerbated by Ethambutol.
- To compile and list drugs known to induce or aggravate LED and "pseudo-LE-Syndrom."
- To identify Ethambutol as a potential new causative agent in drug-induced LED.
Summary:
- A 22-year-old patient with Lupus Erythematosus Disseminatus (LED) experienced disease exacerbation during Ethambutol treatment.
- Ethambutol's role in inducing or worsening LED is presented.
- A comprehensive list of drugs associated with "pseudo-LE-Syndrom" or LED aggravation is provided, with Ethambutol as a novel addition.
Impact:
- Highlights Ethambutol as a potential trigger for Lupus Erythematosus Disseminatus (LED) exacerbation.
- Contributes to the understanding of drug-induced autoimmune diseases.
- Informs clinicians about a broader range of medications that may affect patients with LED.